Cargando…
Adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma
OBJECTIVE: No standard postoperative adjuvant chemotherapy has ever been established in node-positive esophageal squamous cell carcinoma (ESCC). This is a study to explore the effect of postoperative paclitaxel (PTX) and cisplatin (DDP) in lymph node-positive, completely resected thoracic ESCC patie...
Autores principales: | Zhang, Liangze, Li, Weiwei, Lyu, Xiao, Song, Yan, Mao, Yousheng, Wang, Shaoming, Huang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422417/ https://www.ncbi.nlm.nih.gov/pubmed/28536494 http://dx.doi.org/10.21147/j.issn.1000-9604.2017.02.08 |
Ejemplares similares
-
Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node‐positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?
por: Fang, Shuogui, et al.
Publicado: (2022) -
Adjuvant chemotherapy for lymph node positive esophageal squamous cell cancer: The prediction role of low mean platelet volume
por: Liu, Xiaoling, et al.
Publicado: (2022) -
Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma
por: Jeon, Yeong Jeong, et al.
Publicado: (2023) -
Prognostic impact of thoracic duct lymph node metastasis in esophageal squamous cell carcinoma
por: Matsuda, Satoru, et al.
Publicado: (2021) -
Phase II study of adjuvant chemotherapy with paclitaxel and nedaplatin for uterine cervical cancer with lymph node metastasis
por: Takekuma, Munetaka, et al.
Publicado: (2018)